The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
December 4th 2024
CDC, NIH, and AMA recommend PEMs to be at a 6th-to-8th-grade reading level, while assessed materials were readable at high school or higher levels.
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
New Axial and Peripheral Spondyloarthritis Classification Criteria
November 30th 2011The spectrum of spondyloarthritis disorders-typically including ankylosing spondylitis, arthritis associated with inflammatory bowel disease, reactive arthritis, psoriatic arthritis, and undifferentiated SpA-are related clinically and genetically but are distinct entities.
Dupuytren Referrals and Awareness Lacking, Survey Shows
November 30th 2011Close to half (41%) of patients with Dupuytren contracture are not receiving prompt referral to a specialist, visiting their general practitioner (GP)/doctor almost 3 times before being referred, according to a Pfizer UK Limited survey of 700 GPs from 6 European countries.
Key Osteoarthritis, Rheumatoid Arthritis, and Lupus Findings From ACR Meeting
November 12th 2011Persons as young as 45 to 64 years will account for more than half of new diagnoses of knee osteoarthritis (OA) over the next decade as the rate of disease in younger persons increases. A vaccine designed to reeducate the immune system has been shown to be safe and feasible in the treatment of patients with rheumatoid arthritis (RA).
ACR 2011: Dealing with Loss of Data in Clinical Trials
There is a lot of work involved in producing a successful clinical trial. Even the planning stage alone can take a significant amount of time. But when data is incomplete-especially in longitudinal clinical trials-it can be a real struggle for organizers.
ACR 2011: Early Aggressive Therapy in Polyarticular Juvenile Idiopathic Arthritis [VIDEO]
November 8th 2011One of the more exciting parts of the conference has been the ability to sit in and listen to highlighted studies that are selected by the ACR. This press conference features Carol Wallace, MD, Seattle Children's Hospital and Research Institute, Seattle, WA, speaking about her study and answering questions from the audience.
ACR 2011: Challenges in Helping Patients Understand Risks and Benefits of Medications [VIDEO]
November 8th 2011Marcus Owen, MD, practices rheumatology and internal medicine in Nashville, TN. In this video, Dr. Joseph Kim talks with Dr. Owen about what he hopes to take away from this year's ACR conference and also speaks about some of the biggest challenges he faces in helping patients understand risk and benefit of medications.
ACR 2011: Advice on Contract Negotiations for Physicians
Negotiating a contract for a position in academia, industry, or private practice can be a complex and nerve-wracking process, with many physicians unsure of which questions to ask and which elements of their compensation beyond salary are negotiable.
ACR 2011: The Debate Over Medical Marijuana Continues
Although there is some evidence showing treatment with medical marijuana can benefit patients with arthritis, chronic pain, and other conditions, there are also serious concerns over quality control, non-standardized dosing, and other potential safety risks.
ACR 2011: Transitioning the Pediatric Rheumatology Patient
Transitioning an adolescent or teenager from a pediatric rheumatologist to an adult rheumatologist can be a very delicate and complicated process. With so many pitfalls along the way, it's easy to see why this problem has been occurring more and more. The good news? It's a very "fixable" problem.
ACR 2011: The Goal of Meaningful Use Is to Improve the Quality of Care
With Medicare and Medicaid incentives scheduled to start this year, physicians owe it to their patients and their practices to learn about the requirements to qualify as meaningful users of health care technology.
ACR 2011: Getting Policymakers to Take Musculoskeletal Conditions More Seriously
Professor Anthony Woolf, Consultant Rheumatologist at the Royal Cornwall Hospital and Professor of Rheumatology at the Peninsula Medical School, Truro, UK, posed a very important question in his presentation at ACR on Monday: "How do we get policymakers to take musculoskeletal conditions seriously?"